RxDoctor Payments Data

Jason Litak, MD

MOHS-Micrographic Surgery · Santa Monica, CANPI 1750575247

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations.

$5,303in general payments, 2019–2025

Across 221 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$982
  • AbbVie$805
  • Johnson & Johnson$682
  • Sun Pharmaceutical Industries Inc.$495
  • Sanofi$451
  • UCB, Inc.$280
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$5,17498%
  • Education$1302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,303 in reported general payments places this provider in the 70th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$723,989
Medicare patients
740
Services billed
5,042

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole68$1,319
Clobetasol Propionate25$1,115
Fluorouracil13$980
Fluocinonide13$525
Triamcinolone Acetonide48$428
Doxycycline Hyclate14$380
ValacyclovirValacyclovir Hcl18$348
Metronidazole17$329
Cephalexin22$317
Hydroxyzine Hcl12$190
Gabapentin22$162
Mupirocin24$117

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →